| scholarly article | Q13442814 |
| P50 | author | Tsuyoshi Chiba | Q47121768 |
| P2093 | author name string | Toru Nakazawa | |
| Takao Satou | |||
| Masaki Tabuchi | |||
| Tatsuki Itoh | |||
| P2860 | cites work | Interleukin-1 receptor antagonist gene polymorphism and susceptibility to ischemic stroke. | Q54460447 |
| Interleukin 1 gene cluster, myocardial infarction at young age and inflammatory response of human mononuclear cells. | Q54460453 | ||
| Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization | Q69071278 | ||
| Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration | Q80866184 | ||
| Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension | Q82107478 | ||
| Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture | Q85056527 | ||
| Dynamic changes of inflammatory markers in brain after hemorrhagic stroke in humans: a postmortem study | Q24634239 | ||
| Dietary restriction suppresses inflammation and delays the onset of stroke in stroke-prone spontaneously hypertensive rats | Q28567992 | ||
| Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
| Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor | Q30449817 | ||
| Dual role of tumor necrosis factor alpha in brain injury | Q33879032 | ||
| Role of IL-1alpha and IL-1beta in ischemic brain damage. | Q34084693 | ||
| Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association | Q34153132 | ||
| Beyond lipid lowering: the role of statins in vascular protection | Q34875099 | ||
| Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. | Q34894419 | ||
| Inflammatory bio-markers and cardiovascular risk prediction | Q34941391 | ||
| Prevention of stroke and dementia with statins: Effects beyond lipid lowering | Q35077221 | ||
| A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients | Q35484320 | ||
| Inflammation and infections as risk factors for ischemic stroke | Q35538798 | ||
| Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis | Q35932795 | ||
| Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease | Q37049901 | ||
| Transport of interleukin-1 across cerebromicrovascular endothelial cells | Q37230682 | ||
| NF‐κB and innate immunity in ischemic stroke | Q37252167 | ||
| Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke | Q37533575 | ||
| Endothelial cell biology: role in the inflammatory response | Q37833051 | ||
| The pro- and anti-inflammatory properties of the cytokine interleukin-6. | Q37836084 | ||
| Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic target | Q37959134 | ||
| Low serum cholesterol and the risk of cerebral haemorrhage | Q41224189 | ||
| Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke | Q44690384 | ||
| Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects | Q45244815 | ||
| Acetylsalicylic acid provides cerebrovascular protection from oxidant damage in salt-loaded stroke-prone rats | Q46723633 | ||
| Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure | Q46989147 | ||
| Dietary protein, but not carbohydrate, is a primary determinant of the onset of stroke in stroke-prone spontaneously hypertensive rats | Q47701580 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 701976 | |
| P577 | publication date | 2012-12-27 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Interleukin-1β accelerates the onset of stroke in stroke-prone spontaneously hypertensive rats | |
| P478 | volume | 2012 |
| Q37705173 | BRG1 variant rs1122608 on chromosome 19p13.2 confers protection against stroke and regulates expression of pre-mRNA-splicing factor SFRS3. |
| Q90197778 | Brain perivascular macrophages contribute to the development of hypertension in stroke-prone spontaneously hypertensive rats via sympathetic activation |
| Q44861750 | Cardiac phenylethanolamine N-methyltransferase: localization and regulation of gene expression in the spontaneously hypertensive rat. |
| Q37351594 | Chemokines and neurodegeneration in the early stage of experimental ischemic stroke |
| Q36568185 | Interleukin-1 Receptor Activation Potentiates Salt Reabsorption in Angiotensin II-Induced Hypertension via the NKCC2 Co-transporter in the Nephron. |
| Q36244982 | Models and mechanisms of vascular dementia |
| Q48239109 | NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension |
| Q48685600 | Neuroprotection by progesterone after transient cerebral ischemia in stroke-prone spontaneously hypertensive rats |
| Q38959463 | Relation between neonatal malnutrition and gene expression: inflammasome function in infections caused by Candida Albicans |
| Q39342382 | Role of the Immune System in Hypertension |
| Q53185348 | Serum Amyloid P-Component Prevents Cardiac Remodeling in Hypertensive Heart Disease. |
| Q38417525 | Systemic inflammation as a therapeutic target in acute ischemic stroke |
Search more.